-
Who we are
Who we are
Novavax is a global biotechnology company with a proven vaccine technology. We are focused on developing our R&D assets and establishing partnerships to leverage the value of our technology to help protect health.
Discover our scienceLearn about our validated protein-based nanoparticle and Matrix-M™ adjuvant technology.
-
What we do
What we do
Novavax is focused on using our proven vaccine technology to help protect health through the development of our R&D assets and establishing partnerships
Latest UpdatesStay current with Novavax news as we make progress in discovering and developing innovative vaccines to help protect against serious infectious diseases.
-
Blog
Blog
Novavax is committed to accelerating the development of new and promising vaccines and sharing information based on years of study and experience.
News & Media
Press releases & statements
Mar 11, 2025
Press release
Corporate and finance
Feb 27, 2025
Corporate and finance
Feb 27, 2025
Corporate and finance
Dec 10, 2024
COVID-19,Seasonal influenza
Dec 4, 2024
Press release
Corporate and finance
Nov 15, 2024
Corporate and finance
Nov 13, 2024
Corporate and finance
Showper page